Insights on an FDA-approved multi-cancer detection test, the impact of obesity pharmacotherapy adherence on weight loss outcomes, and more.
In this episode of Weekly Dose, we explore a range of clinical studies, from patient preferences in atopic dermatitis treatment to the impact of social determinants of health on hormonal therapy use in midlife women. We also discuss the FDA's Breakthrough Device designation for a multi-cancer detection test, the challenges in deimplementing low-value cancer screenings, and the impact of obesity pharmacotherapy adherence on weight loss outcomes. Tune in for these important insights shaping clinical practice across multiple specialties.
Enhance your clinical practice with the Patient Care newsletter, offering the latest evidence-based guidelines, diagnostic insights, and treatment strategies for primary care physicians.